CRVL Chairman Gordon sells 8,000 shares in 2 transactions for $2,925,306.60 (Nov 29–Dec 2)
Chairman Clemons V Gordon executed 2 separate sales totaling 8,000 shares for $2,925,306.60, reducing his stake by 3.2% to 241,584 shares post-transaction. The stock has risen 17.9% over the past 30 days and 14.4% over 90 days, trading at $118.70 (-3.9% from its 52-week high of $123.54). Gordon's cross-ticker track record shows a 100.00% well-timed sell rate historically, though his 5 prior CRVL sales remain too recent to measure outcomes. With CRVL trading at a P/E of 24.94 and posting 10.7% annual revenue growth on a $2.0B market cap, this sale represents a material but not controlling reduction in the Chairman's position during a period of positive price momentum.
Chairman V. Gordon Clemons sells 11,200 shares of CRVL for $4.1M ($368.80 avg) over 5 days, retaining 249,584 shares post-transaction
Clemons executed 3 separate sales totaling 11,200 shares for $4,130,612.12 between 2024-11-22 and 2024-11-26, reducing his stake by 4.3% to 249.6K shares. The blended average price of $368.80 significantly exceeds the current price of $123.54, indicating these sales occurred near a local peak; however, stock price has risen 21.9% in the 30 days and 17.8% in the 90 days since filing, contradicting any signal that the sales prefigured a decline. His same-ticker prior sales at CRVL (2023-11-14 and 2023-09-15) showed well-timed outcomes at the 90-day mark, but those measurable results occurred in a different market window; the current 30-day and 90-day periods post-transaction show price appreciation rather than decline. The company's 10.7% annual revenue growth and P/E of 25.95 suggest a moderately valued, growing business; the sale does not appear driven by deteriorating fundamentals.
CRVL Chairman sells 5,000 shares for $1.8M at $363.70 avg; prior 5 same-ticker sales 100% well-timed with 90d returns averaging -60% to -70%.
Clemons V Gordon, Chairman of Corvel Corp, executed three separate sales totaling 5,000 shares for $1,818,476.30 between November 8–12, 2024, reducing holdings by 1.9% to 261,584 shares. This filing is material given the Chairman's position and the transaction size. The insider's prior 5 sales at this ticker (August–November 2023) were uniformly well-timed; each showed negative 90-day returns ranging from -60.6% to -70.2%, meaning the stock declined after every prior sale—a 100% timing accuracy rate at this specific ticker. His cross-ticker track record also shows a 90d well-timed rate of 100.00% across 7 prior sells. The current market context shows the stock near its 52-week high (currently $118.48, only -1.9% from the $120.77 peak) and up +12.2% over 90 days, which contrasts with the historical post-sale declines. This convergence of historical precision timing by the Chairman and the stock's current elevated valuation within the 52-week range warrants close investor attention to forward-looking signals.
